US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Avita Medical, Inc. - Common Stock (NQ:RCEL)

13.21 -0.12 (-0.90%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Avita Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
AVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow Breakeven
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce Second Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports First Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Names Cary Vance as Chief Executive Officer
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Announce First Quarter 2026 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCEL
From Pomerantz LLP
Via GlobeNewswire
News headline image
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
News headline image
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical Announces Changes to its Board of Directors
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare Conference
From AVITA Medical
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
AVITA Medical to Host Investor Webinar Briefing
From AVITA Medical
Via GlobeNewswire
News headline image
AVITA® Medical Reports Third Quarter 2025 Financial Results
From AVITA Medical
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >